Abstract
The epidemiologic evidence establishing a low HDL cholesterol level as an independent risk factor for atherosclerosis and coronary heart disease is convincing beyond all possible doubt. However, the mechanisms by which a low HDL level predisposes to and a high HDL level protects against atherosclerosis are not firmly established. By all odds the most widely accepted hypothesis is that put forward by Glomset almost 20 years ago, namely, the hypothesis that HDL is involved in “reverse cholesterol transport” (1). Based on his studies of lecithin-cholesterol acyltransferase, Glomset saw that HDL could accept free cholesterol from tissues and that this free cholesterol could be converted to the ester form by the action of LCAT. This would then allow the surface of the HDL molecule to accept another molecule of free cholesterol from the cells, and so on. This hypothesis is supported by many cell culture studies showing that HDL can act as an acceptor of cholesterol from cells overloaded with cholesterol [reviewed by Reichl and Miller (2)]. On the other hand, lipoprotein-deficient serum or even serum albumin alone can also facilitate the removal of cholesterol from cholesterol-loaded cells. Studies by Oram and colleagues, demonstrating a set of saturable binding sites on cells in culture that are up-regulated when the cells are loaded with cholesterol, also support the hypothesis (3,4) and several other groups have either observed specific, saturable binding of HDL or have actually partially purified a putative HDL receptor (see ref. 2). However, the results of these in vitro studies cannot be fully evaluated until there is a translation to the in vivo situation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Glomset JA (1968) The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 9:155–67
Reichl D, Miller NE (1986) The anatomy and physiology of reverse cholesterol transport. Clin Sci 70:221–231
Oram JF, Albers JJ, Cheung MC, Bierman EL (1981) The effect of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. J Biol Chem 256:8348–8356
Biesbroeck R, Oram JF, Albers JJ, Bierman EL (1983) Specific high affinity binding of high density lipoprotein to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest 71:525–539
Schaefer EJ, Blum CB, Levy RI et al. (1978) Metabolism of high-density lipoprotein apolipoprotein in Tangier disease. N Engl J Med 299:905–910
Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB, Jr (1982) Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis 2:16–26
Glass C, Pittman RC, Weinstein DB, Steinberg D (1983) Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci USA 80:5435–5439
Pittman RC, Steinberg D (1984) Sites and mechanisms of uptake and degradation of high density and low density lipoproteins. L Lipid Res 25:1577–1585
Pittman RC, Steinberg D (1985) A novel mechanism by which high density lipoprotein selectively delivers cholesterol esters to the liver. In: Greten H, Windler E, Beisiegel U (eds) Receptor-mediated uptake in the liver. Springer, Berlin Heidelberg New York Tokyo, pp 108–119
Mahley RW (1978) Alterations in plasma lipoproteins induced by cholesterol feeding in animals including man. In: Dietschy JM, Gotto AM, Ontko JA (eds) Disturbances of lipid and lipoprotein metabolism. Am Physiol Soc, Bethesda, MD, pp 181–197
Mahley RW, Innerarity TL, Bersot TP, Lipson A, Margolis S (1978) Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high cholesterol. Lancet Oct 14:807–809
Pitas RE, Innerarity TL, Arnold KS, Mahley RW (1979) Rate and equilibrium constants for binding of apo-E HDLC (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLC. Proc Natl Acad Aci USA 76:3211–2315
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Steinberg, D. (1987). Transport of Cholesterol and Cholesterol Esters by HDL. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-71702-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71704-8
Online ISBN: 978-3-642-71702-4
eBook Packages: Springer Book Archive